Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase 1 study of MVT-602 in healthy women volunteers

Trial Profile

A phase 1 study of MVT-602 in healthy women volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Oct 2018

At a glance

  • Drugs MVT 602 (Primary)
  • Indications Female infertility
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Oct 2018 According to a Myovant Sciences media release, results from this study were presented at the 2018 American Society for Reproductive Medicine (ASRM) Annual Congress.
    • 10 Oct 2018 Results presented in a Myovant Sciences media release.
    • 13 Jun 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top